These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18685308)

  • 21. [Analysis of the result of 409 cases with liver cirrhosis and severe hepatitis by using the model for end-stage liver disease].
    Song CH; Chen LM; Zhang LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):168-70. PubMed ID: 17653326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition.
    Putchakayala K; Polensky S; Fitzhugh J; Cohran V; Buchman A; Fryer J
    JPEN J Parenter Enteral Nutr; 2009; 33(1):55-61. PubMed ID: 18941030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different methods of creatinine measurement significantly affect MELD scores.
    Cholongitas E; Marelli L; Kerry A; Senzolo M; Goodier DW; Nair D; Thomas M; Patch D; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):523-9. PubMed ID: 17323365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.
    Kamath PS; Kim WR
    Clin Liver Dis; 2009 Feb; 13(1):63-66. PubMed ID: 19150310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The model for end-stage liver disease comes of age.
    Freeman RB
    Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictors of massive blood transfusion in liver transplantation for patients with benign end-stage liver disease].
    Feng ZY; Jin XD; Chen YZ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3040-4. PubMed ID: 19192401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests].
    Hofmann WP; Rädle J; Moench C; Bechstein W; Zeuzem S
    Z Gastroenterol; 2008 Nov; 46(11):1283-9. PubMed ID: 19012201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D; Castillo E; Kumer S; Abouljoud M; Divine G; Pelletier S
    Transplant Proc; 2009; 41(1):216-8. PubMed ID: 19249517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.
    Gitto S; Lorenzini S; Biselli M; Conti F; Andreone P; Bernardi M
    Dig Liver Dis; 2009 Oct; 41(10):700-6. PubMed ID: 19502118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation.
    Rajekar H; Wai CT; Majeed TA; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Soosaynathan C; Tan KC
    Transplant Proc; 2008 Oct; 40(8):2492-3. PubMed ID: 18929776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.